Clinical Trials Directory

Trials / Unknown

UnknownNCT02275247

Perioperative Neuroprotection of Stellate Ganglion Block

Preventive Effect of Stellate Ganglion Block on Cerebral Vasospasm in Patients Undergoing Aneurysm Surgery

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
General Hospital of Ningxia Medical University · Academic / Other
Sex
All
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

To investigate whether stellate ganglion block is helpful to brain protection during cranial aneurysm surgery

Detailed description

The vasospasm after cranial aneurysm surgery have a higher incidence, but not have an ideal treatment method. At present, the medical treatment is very limited effect to prevent the perioperative cerebral ischemia.Stellate ganglion block (SGB)is an effective and well-tolerated approach to the treatment of CVS in various clinical settings.Resent study indicated that SGB has a protective effect on delayed cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.Therefore,we hypothesized that the preoperative SGB would be a effective treatment for improvement of vasospasm after cranial aneurysm surgery.

Conditions

Interventions

TypeNameDescription
DRUGStellate Ganglion Blockstellate ganglion block will be administered using either 6-8mL saline (Group 1) or 0.25% ropivacaine 6-8mL (Group 2)

Timeline

Start date
2014-08-01
Primary completion
2015-10-01
Completion
2016-10-01
First posted
2014-10-27
Last updated
2016-05-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02275247. Inclusion in this directory is not an endorsement.